Viewing Study NCT03098160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-25 @ 3:02 AM
Study NCT ID: NCT03098160
Status: UNKNOWN
Last Update Posted: 2017-10-30
First Post: 2017-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Sponsor: Threshold Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
None Melanoma View
None Squamous Cell Carcinoma of the Head and Neck View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Hypoxia View
None Evofosfamide View
None Ipilimumab View
None TH-302 View